Related Experiment Video
Updated: Dec 13, 2025

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Fluvastatin and atorvastatin induce programmed cell death in the brain eating amoeba Naegleria fowleri
Aitor Rizo-Liendo1, Ines Sifaoui2, Iñigo Arberas-Jiménez1
1Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, La Laguna, Tenerife, 38203 Islas Canarias, Spain; Departamento de Obstetricia, Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad De La Laguna, La Laguna, Tenerife, 38203 Islas Canarias, Spain.
Abstract:
Naegleria fowleri is the causative agent of a type of encephalitis called Primary Amoebic Encephalitis (PAM). Almost 98 % of PAM cases reported worldwide are fatal and affect mostly immunocompetent children and young adults. The current therapeutic option against PAM cases includes a combination of miltefosine, amphotericin B and other drugs which are unfortunately associated with severe side effects. In a recent study in our group, statins were tested in vitro against Naegleria fowleri trophozoites showing activity against these pathogens at low concentrations causing low toxicity. Consequently, there is an urgent need to develop novel PAM therapeutic options. Therefore, this study was undertaken to evaluate the pathway of cell death induced by two of the previously tested molecules, fluvastatin and atorvastatin. Moreover, these statins were compared to miltefosine and amphotericin B. Furthermore, the induction of Programmed Cell Death (PCD) instead of necrosis in treated amoebae would be the ideal situation since necrosis could lead to non-desired inflammation processes in the infected individual. The obtained results revealed that both statins induced PCD in the treated amoebae after the observation of condensed chromatin, cell membrane damages, mitochondrial membrane potential and ATP levels collapse and ROS generation. In conclusion, both fluvastatin and atorvastatin could be potential new candidates for PAM therapy since they are active at low concentrations, induce low toxicity and cause PCD in the treated amoebae, hence avoiding the activation of inflammation pathways.
Insights
Flাইভastatin and atorvastatin show promise for treating Primary Amoebic Encephalitis (PAM). These statins effectively kill Naegleria fowleri by inducing programmed cell death with low toxicity, offering a potential new therapy.
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Naegleria fowleri causes Primary Amoebic Encephalitis (PAM), a nearly always fatal infection.
- Current PAM treatments have severe side effects and limited efficacy.
- Statins have demonstrated in vitro activity against Naegleria fowleri with low toxicity.
Purpose of the Study:
- To investigate the cell death pathways induced by fluvastatin and atorvastatin in Naegleria fowleri.
- To compare the efficacy and cell death mechanisms of fluvastatin and atorvastatin against miltefosine and amphotericin B.
- To determine if statins induce programmed cell death (PCD) to avoid inflammation.
Main Methods:
- Treatment of Naegleria fowleri trophozoites with fluvastatin and atorvastatin.
- Assessment of cell death markers including chromatin condensation, membrane integrity, mitochondrial potential, ATP levels, and ROS generation.
- Comparison of statin-induced cell death with that induced by miltefosine and amphotericin B.
Main Results:
- Both fluvastatin and atorvastatin induced programmed cell death (PCD) in Naegleria fowleri.
- Observed PCD indicators included chromatin condensation, cell membrane damage, mitochondrial dysfunction, and ATP depletion.
- Statins also triggered reactive oxygen species (ROS) generation in the treated amoebae.
Conclusions:
- Fluvastatin and atorvastatin are potential candidates for PAM therapy due to their efficacy at low concentrations and low toxicity.
- Statins induce PCD in Naegleria fowleri, which may prevent inflammatory responses associated with necrosis.
- Developing statin-based therapies could offer a safer and more effective treatment for PAM.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway
Apoptosis

